At. Ozcelikay et al., Reversal effects of L-arginine treatment on blood pressure and vascular responsiveness of streptozotocin-diabetic rats, PHARMAC RES, 41(2), 2000, pp. 201-209
In the present study, we examined the reversal effects of L-arginine (L-ARG
) treatment in vivo on blood pressure and on vascular responsiveness of chr
onic diabetic rats. Twelve weeks after streptozotocin (STZ) injection, the
systolic blood pressures (SBP) of diabetic groups have been found to be sig
nificantly higher compared with that of control groups. L-ARG treatment for
4 weeks, begun 12 weeks after the onset of diabetes, induced a significant
fall in SBP of diabetic rats. Maximal contractile response and sensitivity
(pD(2) value) of the aortae to phenylephrine (PE) were significantly enhan
ced in diabetic rats compared with control subjects. Treatment of diabetic
rats with L-ARG completely reversed the increases in responsiveness and sen
sitivity of aortae to PE. The relaxation response to acetylcholine (ACh), b
ut not to sodium nitroprusside (SNP), in diabetic aorta has been found to b
e significantly decreased when compared with control subjects. The in vivo
treatment with L-ARG reversed the decreased ACh responses to the control le
vel. Plasma malondialdehyde (MDA) level of diabetic rats was also significa
ntly higher than control subjects. However, L-ARG treatment normalized the
increase in MDA level of plasma of diabetic rats. All of the effects of L-A
RG treatment were found to be specific for diabetic rats but not control su
bjects. These results show that L-ARG treatment in vivo has a reversal effe
ct on impaired vascular responses and increased oxidative stress. The prese
nt findings also suggest that oxidative stress that occurred in diabetes mi
ght cause or contribute to the development of hypertension by affecting vas
cular reactivity. On the other hand, the lipid peroxidation-lowering effect
of L-ARG map account for its beneficial effect on SBP and vascular respons
iveness of diabetic rats. (C) 2000 Academic Press.